CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Debt / NOTE 2.500%11/0
Market price (% of par)
255.5%
Total 13F principal
$210,563,536
Principal change
+$11,691,518
Total reported market value
$538,919,506
Number of holders
36
Value change
+$31,311,702
Number of buys
15
Number of sells
16

Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 as of Q1 2014

As of 31 Mar 2014, CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 was held by 36 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $210,563,536 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, Polar Securities Inc., BlackRock Advisors LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Whitebox Advisors LLC, BlackRock Institutional Trust Company, N.A., BlackRock Group LTD, DEUTSCHE BANK AG\, JPMORGAN CHASE & CO, and GUARDIAN LIFE INSURANCE CO OF AMERICA. This page lists 36 institutional bondholders reporting positions for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.